Konstantinos Papathanasiou

Dr. Konstantinos Papathanasiou

University of Wolverhampton
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2012 in Chemistry of Materials
Verified
Journal Article
Closed access
Rosario Mercedes Pérez ColodreroRosario Mercedes Pérez Colodrero
Rosario Mercedes Pérez Colodrero
KPKonstantinos Papathanasiou
Konstantinos Papathanasiou
NSNikoleta Stavgianoudaki
Nikoleta Stavgianoudaki
POPascual Olivera-Pastor
Pascual Olivera-Pastor
ELEnrique R Losilla
Enrique R Losilla
ACAurelio Cabeza
Aurelio Cabeza

14 July 2016 in Inorganic Chemistry
Verified
Journal Article
Closed access
MBMontse Bazaga-García
Montse Bazaga-García
GAGiasemi K. Angeli
Giasemi K. Angeli
KPKonstantinos Papathanasiou
Konstantinos Papathanasiou
ISInés Ruiz Salcedo
Inés Ruiz Salcedo
POPascual Olivera-Pastor
Pascual Olivera-Pastor
KDKonstantinos D. Demadis
Konstantinos D. Demadis

27 March 2020 in Chemical Communications
Verified
Journal Article
Open access
PDF file
MVMaria Vassaki
Maria Vassaki
KPKonstantinos Papathanasiou
Konstantinos Papathanasiou
CHChrystalleni Hadjicharalambous
Chrystalleni Hadjicharalambous
DCDaphne Chandrinou
Daphne Chandrinou
Petri TurhanenPetri Turhanen
Petri Turhanen
KDKonstantinos D. Demadis
Konstantinos D. Demadis
In this paper we report drug delivery systems that are based on phosphonate MOFs. These employ biologically-acceptable metal ions (e.g. Ca2+ and Mg2+) and several anti-osteoporosis bisphosphonate drugs (etidronate, pamidronate, alendronate and neridronate), as the organic linkers. These materials have been synthesized, structurally characterized, and studied for the self-sacrificial release (by pH-driven dissolution) of the bisphosphonate active ingredient. They exhibit variable release rates and final % release, depending on the actual structure of the metal-bisphosphonate material. Their cytotoxicity profiles match those of the active ingredients.

30 January 2019 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
ILIngrid Lehman-Andino
Ingrid Lehman-Andino
JSJing Su
Jing Su
KPKonstantinos Papathanasiou
Konstantinos Papathanasiou
TETeresa M. Eaton
Teresa M. Eaton
JJJiwen Jian
Jiwen Jian
KKKonstantinos Kavallieratos
Konstantinos Kavallieratos
Selectivity for An(III) vs. Ln(III) binding and extraction using dipicolinamide analogs containing the CO vs. CS groups was investigated in solution and the gas-phase, and by DFT calculations. The results show higher selectivity for complex formation and extraction for Am(III) vs. Eu(III) for the softer dithioamide vs. the diamide ligand, while in CH3CN the diamide binds more strongly than the thioamide to several Ln(III), forming 1 : 1 complexes.

6 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KPKonstantinos Papathanasiou
Konstantinos Papathanasiou
Petri TurhanenPetri Turhanen
Petri Turhanen
SBStephan I. Brückner
Stephan I. Brückner
EBEike Brunner
Eike Brunner
KDKonstantinos D. Demadis
Konstantinos D. Demadis
Easy-to-prepare drug delivery systems, based on smart, silica gels have been synthesized, characterized, and studied as hosts in the controlled release of bisphosphonates. They exhibit variable release rates and final % release, depending on the nature of bisphosphonate (side-chain length, hydro-philicity/-phobicity, water-solubility), cations present, pH and temperature. These gels are robust, injectable, re-loadable and re-usable.

8 December 2018 in Pure and Applied Chemistry
Verified
Journal Article
Open access
PDF file
KPKonstantinos Papathanasiou
Konstantinos Papathanasiou
MVMaria Vassaki
Maria Vassaki
ASArgyro Spinthaki
Argyro Spinthaki
FAFanouria-Eirini G. Alatzoglou
Fanouria-Eirini G. Alatzoglou
ETEleftherios Tripodianos
Eleftherios Tripodianos
KDKonstantinos D. Demadis
Konstantinos D. Demadis
(Poly)phosphonic acids constitute an exciting family of phosphorus compounds. One of the attractive attributes of these molecules is the rich chemistry of the phosphonate moiety, and, in particular, its high affinity for metal ions and mineral surfaces. Whether the phosphonate group belongs to a “small” molecule or to a polymeric matrix, phosphonate-containing compounds have found a phalanx of real-life applications. Herein, we address a special category of phosphorus compounds called bisphosphonates (BPs, a.k.a. “-dronates”) and also phosphonate containing polymers. The success of BPs in mitigating osteoporosis notwithstanding, these “-dronate” drugs present a number of challenges. Nevertheless, the main drawback of BPs is their limited oral bioavailability. It is, therefore, imperative to design and fabricate “smart” systems that allow controlled delivery of the active BP agent. Here, easy-to-prepare drug delivery systems are presented based on silica gels. These have been synthesized, characterized, and studied as hosts in the control release of several BP drugs. They exhibit variable release rates and final % release, depending on the nature of bisphosphonate (side-chain length, hydro-philicity/-phobicity, water-solubility), cations present, pH and temperature. These gels are robust, injectable, re-loadable and re-usable. Furthermore, alternative drug delivery systems are presented that are based on metal-organic frameworks (MOFs). In these biologically acceptable inorganic metal ions have been incorporated, together with BPs as the organic portion. These materials have been synthesized, characterized, and studied for the self-sacrificial release (by pH-driven dissolution) of the BP active ingredient. Several such materials were prepared with a variety of bisphosphonate drugs. They exhibit variable release rates and final % release, depending on the actual structure of the metal-bisphosphonate material. Lastly, we will present the use of phosphonate-grafted polymers as scale inhibitors for water treatment applications.